Daily aggregation of the latest industry news from authoritative global and Chinese sources, with AI-generated Chinese summaries to help professionals stay ahead.
Researchers at LSU's Pennington Biomedical Research Center have identified a previously underappreciated role for tiny structures inside cells called peroxisomes in protecting insulin and maintaining the health and maturity of insulin-producing pancreatic beta cells.
The investigational anti-interleukin-6 (IL-6) monoclonal antibody pacibekitug produced sustained reductions in inflammation-related biomarkers through six months in patients with chronic kidney disease and elevated inflammatory risk associated with heart disease.
A newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC). Using a small-molecule compound, the new approach helps mitigate toxicity issues common with treatment, offering a safe and feasible strategy for those with end-stage disease. This research was published in the September issue of The Journal of Nuclear Medicine.
Nurses and physicians often recognize what kind of care a patient deserves at a given moment, whether it is more time at the bedside, a change in pain management or a detailed conversation about the goals of a specific treatment. However, these health care professionals sometimes find themselves unable to follow through because of external factors, ranging from understaffing and resource shortages to institutional policies and regulations.
Previously, the primary endpoint results of the NRG-LU005 (NCT03811002) study assessing the addition of the immunotherapy drug atezolizumab (Tecentriq) to standard-of-care concurrent chemoradiation for limited-stage small-cell lung cancer were reported at the American Society for Radiation Oncology 2024 Annual Meeting. Those results showed that adding atezolizumab did not improve overall survival (OS) for this patient population.
Early initiation of statins after diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study presented at ESC Congress 2026 and published in The Lancet Regional Health – Europe.
A baby's brain is always listening, watching and learning—even when the world around it is chaotic and makes no sense.